1Appay V, Brown A, Cfibbes S, et al. Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants[J]. J Biol Chem, 1999,274(39):27505-27512.
2Wong M, Uddin S, Majchrzak B, et al. Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells [J]. JBiol Chem,2001,276(14):11427-11431.
3Moriwaki Y, Yamamoto T, Shibutani Y, et al. Elevated levds of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy [J]. Metabolism, 2003,52(5):605-608.
4Roestenberg P, van Nieuwenhoven FA, Wieten L,et al. Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy[J]. Diabetes Care,2004,27(5):1164-1170.
5Sassy-Prigent C, Heudes D, Mandet C, et al. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats [J]. Diabetes,2000,49(3):466-475.
6Nakajima K, Tanaka Y, Nomiyama T, et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects[J]. Diabetes Care, 2003,26(3):892-898.
7Chow F, Ozols E, Nikolic-Paterson DJ, et al. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury [J]. Kidney Int, 2004,65(1):116-128.
8Locati M, Deuschle U, Massardi ML, et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes[J]. J Immunol, 2002,168(7):3557-3562.
10Morii T, Fujita H, Narita T, et al. Association of monocyte chemoattractam protein-1 with renal tubular damage in diabetic nephropathy [J]. J Diabetes Complica, 2003,17(1):11-15.
二级参考文献12
1WANG S N, laPAGE J, HIRSCHBERG R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy[J]. Kidney Int, 2000, 57: 1002-1014.
2SINGH R, BARDEN A, MORI T, et al. Advanced glycation end products: a review[J]. Diabetologia, 2001,44 : 129-146.
3ROVIN B H, SCHREINER G F. Cell-mediated immunity in glomerular disease[J]. Annu Rev Med, 1991,42.25-33.
4YOUNG B A, JOHNSON R J, ALPERS C E, et al. Cellular events in the evolution of experimental diabetic nephropathy[J]. Kidney Int, 1995,47:935-944.
5BACON K B, PREMACK B A, GARDNER P, et al. Activation of dual T cell signaling pathways by the chemokine RANTES[ J ]. Science, 1995,269 : 1727-1730.
6KUNA P,REDDIGARI S R,SCHALL T J ,et al. RANTES,a monocyte and T lymphocyte chemoatactic cytokine releases histarnine from human basophils[ J ]. J Immunol, 1992,149 : 636-642.
7SCHALL T J, BACON K, TOY K J, et al. Selective attraction of monocyte and T lymphocytes of memory phenotype by cytokine RANTES[ J ]. Nature, 1990,347 : 669-671.
8NATORI Y, SEKIGUCHI M, NATORI Y. Expression of mRNA of C-C chernokines in experimental crescentic glomerulonephritis[ J ]. J Am Soc Nephrol, 1995,6: 845.
